Peers of Inhibitor Therapeutics Inc (INTI)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month free cash flow. Values the entire business on cash available after reinvestment.
Latest EV/FCF
-5.13x
As of Oct 2, 2026
Beyond EV/FCF, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/FCF |
|---|---|
| Oct 2, 2026 | -5.13x |
| Sep 28, 2026 | -5.23x |
| Sep 23, 2026 | -5.23x |
| Sep 22, 2026 | -3.02x |
| Sep 16, 2026 | -4.63x |
| Sep 15, 2026 | -5.23x |
| Sep 11, 2026 | -5.23x |
| Sep 9, 2026 | -4.51x |
EV/FCF = Enterprise Value / Free Cash Flow (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/FCF is especially insightful for capital-intensive businesses.
Read the general EV/FCF definition, formula, and analyst usage guide.
EV/FCF guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison